Previous close | 23.25 |
Open | 23.72 |
Bid | 21.67 x 800 |
Ask | 21.69 x 1100 |
Day's range | 21.36 - 24.23 |
52-week range | 5.65 - 25.74 |
Volume | |
Avg. volume | 11,258,503 |
Market cap | 4.676B |
Beta (5Y monthly) | 1.07 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.01 |
Earnings date | 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 21.15 |
SAN FRANCISCO, July 22, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Kåre Schultz to the company’s Board of Directors.
SAN FRANCISCO, July 15, 2024--Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
As of July 2024, the U.S. stock market is experiencing a notable shift, with major indices like the Nasdaq and S&P 500 facing declines primarily due to a tech selloff, while smaller companies in the Russell 2000 index are on the rise. This environment underscores the relevance of exploring growth companies with high insider ownership, which often signals strong confidence from those closest to the operations and potential resilience in turbulent times.